Princess Dina Mired Named a Top Woman in Cancer Care

The advocate earns her fourth consecutive spot on a global list for her work in cancer policy and patient equity.

Updated on Oct. 21, 2026 in Cancer

A serene, minimalist corridor in a modern research facility featuring a large, subtle medical emblem etched into a clean stone wall.
Princess Dina Mired was named one of the 100 Most Influential Women in Cancer by OncoDaily for 2026, marking her fourth consecutive recognition. AI Illustration. Upload story photo >

Princess Dina Mired of Jordan has been named to the 2026 list of the 100 Most Influential Women in Cancer by OncoDaily. This marks the fourth consecutive year she has been recognized for her advocacy in global cancer control.

Why it matters

The annual list highlights leaders shaping cancer care and policy worldwide, providing a view into the efforts driving systemic change. Recognition in this space underscores the ongoing work toward achieving more equitable healthcare access for patients across the globe.

OncoDaily recognizes 100 women annually for contributions to cancer research, policy, and advocacy. Princess Dina Mired has maintained a presence on this list for each of the four years since its 2023 debut.

The players

Princess Dina Mired

A prominent advocate for equitable cancer care and health policy who has served as President of the Union for International Cancer Control.

OncoDaily

A publication that tracks cancer research and healthcare developments and publishes annual lists of leaders in the oncology field.

Union for International Cancer Control

A global health organization that leads initiatives to reduce the worldwide cancer burden through advocacy and policy.

King Hussein Cancer Foundation

A major non-profit organization dedicated to cancer treatment and research advocacy based in Jordan.

European Organisation for Research and Treatment of Cancer Cancer Research Fund

A research entity focused on advancing cancer treatment standards and coordinating large-scale clinical investigations.

The details

The selection process evaluates leaders based on their contributions to cancer care, scientific research, and health policy. Princess Dina Mired has historically advanced global cancer control through her leadership roles at the Union for International Cancer Control and the King Hussein Cancer Foundation. She continues this work as Honorary President of the European Organisation for Research and Treatment of Cancer Cancer Research Fund and through her podcast, Global Health Dialogues with Princess Dina.

Timeline

  1. 2023: OncoDaily launched the annual list of influential women in cancer.

  2. 2026: Princess Dina Mired was included on the list for the fourth consecutive year.

Health Landscape

The recognition of these leaders highlights the shift toward centralized global advocacy in oncology. These efforts serve to bolster the policy frameworks long promoted by organizations like the Union for International Cancer Control.

For readers managing cancer care, this news highlights the importance of staying informed about shifts in global health policy and equity initiatives. Following the work of leading advocates can provide insight into the evolving standards of care and resources available for patient support.

The takeaway

Advocacy plays a central role in transforming cancer research into accessible health policy. Readers interested in the intersection of policy and care can track updates from organizations like the Union for International Cancer Control to better understand the future of cancer treatment access.

Further reading

Learn more about ongoing global developments in Cancer.

Source note: This article includes information reported by Jordan News | Latest News from Jordan, MENA.